Familial MPN Predisposition

被引:0
作者
Tsewang Tashi
Sabina Swierczek
Josef T. Prchal
机构
[1] University of Utah,Division of Hematology and Hematologic Malignancies
来源
Current Hematologic Malignancy Reports | 2017年 / 12卷
关键词
Myeloproliferative neoplasm; Germline predisposition; Family clusters; V617F; 46/1;
D O I
暂无
中图分类号
学科分类号
摘要
Chronic myeloproliferative neoplasms (MPN) characteristically arise from a somatic mutation in the pluripotent hematopoietic stem cell, and most common recurring mutations are in the JAK2, CALR, and cMPL genes. However, these mutations are not founder mutations, but mainly drive the disease phenotype and a pre-existing germline predisposition has been long speculated, but has not been clearly defined to date. Genome-wide association studies in family clusters of MPN have identified a number of genetic variants that are associated with increased germline risk for developing clonal MPN. The strongest association discovered so far is the presence of JAK2 46/1 haplotype, and subsequently, many studies have found additional variants in other genes, most notably in TERT gene. However, these still account for a small fraction of familial MPN, and more in-depth studies including whole genome sequencing are needed to gain better insight into familial genetic predisposition of clonal MPNs.
引用
收藏
页码:442 / 447
页数:5
相关论文
共 246 条
[1]  
Zhuang Z(2012)Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia N Engl J Med 367 922-930
[2]  
Yang C(2013)A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma J Mol Med (Berl) 91 507-512
[3]  
Lorenzo F(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-2405
[4]  
Merino M(2006)The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation Proc Natl Acad Sci U S A 103 6224-6229
[5]  
Fojo T(2003)Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease Blood 102 3793-3796
[6]  
Kebebew E(2013)Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study Leukemia 27 1874-1881
[7]  
Lorenzo FR(2002)Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera Exp Hematol 30 229-236
[8]  
Yang C(2005)Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis Cancer Cell 7 387-397
[9]  
Ng Tang Fui M(2005)A gain-of-function mutation of JAK2 in myeloproliferative disorders N Engl J Med 352 1779-1790
[10]  
Vankayalapati H(2005)A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera Nature 434 1144-1148